A systematic review and meta-analysis support greater reduction of proteinuria in patients with IgA nephropathy.

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways Proteinuria affects most people with complement 3 glomerulopathy ...

Proteinuria is a condition characterised by the presence of excess protein, mainly albumin, in the urine. Generally, the kidneys filter waste products and excess fluids from the blood and excrete them ...

Analysis published in ASN, highlighted compelling evidence that ERAs offer substantial therapeutic benefits for CKD patients.

Low proteinuria does not indicate better kidney outcomes or treatment response in patients with lupus nephritis; ...

Proteinuria is common in the adult population and its clinical significance can vary widely. A clear diagnostic process is needed to identify the cause of the findings and guide the treatment ...

February 16, 2010 — Proteinuria may help predict outcomes in chronic kidney disease (CKD) independent of estimated glomerular filtration rate (eGFR) level, according to the results of a ...

Please provide your email address to receive an email when new articles are posted on . At 36 weeks, patients receiving sparsentan experienced a mean 49.8% reduction in proteinuria from baseline.

Before a drug is marketed in the US, it must be shown to be safe and effective for its intended use. The clearest evidence of a drug's effectiveness comes from studies establishing its effects on ...

Medically reviewed by Jamin Brahmbhatt, MD IgA nephropathy (IgAN) is a kidney condition where antibodies (immune system ...

Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan was associated with a 68.3% reduction in proteinuria at 26 weeks vs. placebo. Of patients treated ...